A Single‐Dose mRNA Vaccine Employing Porous Silica Nanoparticles Induces Robust Immune Responses Against the Zika Virus
Advanced Science · 2024
DOI: 10.1002/advs.202404590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Hojeong Shin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea. Hauptthemen laut MEDLINE: Silicon Dioxide, Nanoparticles, Zika Virus, Zika Virus Infection. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lemonex Inc.
Abstract (Originalsprache)
Recently, lipid nanoparticles (LNPs)‐based mRNA delivery has been approved by the FDA for SARS‐CoV‐2 vaccines. However, there are still considerable points for improvement in LNPs. Especially, local administration of LNPs‐formulated mRNA can cause off‐target translation of mRNA in distal organs which can induce unintended adverse effects. With the hypothesis that large and rigid nanoparticles can be applied to enhance retention of nanoparticles at the injection site, a polyethyleneimine (PEI)‐coated porous silica nanoparticles (PPSNs)‐based mRNA delivery platform is designed. PPSNs not only facilitate localized translation of mRNA at the site of injection but also prolonged protein expression. It is further demonstrated that the development of a highly efficacious Zika virus (ZIKV) vaccine using mRNA encoding full‐length ZIKV pre‐membrane (prM) and envelope (E) protein delivered by PPSNs. The ZIKV prME mRNA‐loaded PPSNs vaccine elicits robust immune responses, including high levels of neutralizing antibodies and ZIKV E‐specific T cell responses in C57BL/6 mice. Moreover, a single injection of prME‐PPSNs vaccine provided complete protection against the ZIKV challenge in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Seoul National University, Seoul, 08826, Republic of Korea.
- Institute of Biotherapeutics Convergence Technology, Lemonex Inc., Seoul, 06683, Republic of Korea.
ORCID-Profile: Dal-Hee Min
Förderung
- Lemonex Inc
Zitieren
APA
Shin, H., Kang, S., Won, C., & Min, D. H. (2024). A Single‐Dose mRNA Vaccine Employing Porous Silica Nanoparticles Induces Robust Immune Responses Against the Zika Virus. Advanced Science. https://doi.org/10.1002/advs.202404590
Vancouver
Shin H, Kang S, Won C, Min DH. A Single‐Dose mRNA Vaccine Employing Porous Silica Nanoparticles Induces Robust Immune Responses Against the Zika Virus. Advanced Science. 2024. doi:10.1002/advs.202404590
BibTeX
@article{Shin2024,
author = {Shin, Hojeong and Kang, Seounghun and Won, Cheolhee and Min, Dal-Hee},
title = {A Single‐Dose mRNA Vaccine Employing Porous Silica Nanoparticles Induces Robust Immune Responses Against the Zika Virus},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202404590}
}
EUVIMED